Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. You look at survival for patients with ...

Multiple myeloma treatment has advanced with new therapies, increasing life expectancy from under 3 years to over a decade. Health disparities persist, with Black patients facing higher diagnosis ...

Patients with multiple myeloma who received a new immunotherapy combination lived significantly longer without their cancer worsening and showed early signs of improved survival in a large ...

Your survival rate for multiple myeloma is likely higher in earlier stages. Younger people often have better outcomes due to ...

Five FDA authorizations from Aug 2023–Apr 2024 expanded relapsed/refractory options, including bispecific/T-cell engager approaches, stem-cell mobilization, and two CAR T-cell products. Outcomes in ...

Myeloma, often called multiple myeloma, is a type of blood cancer that affects plasma cells in the bone marrow. Because its symptoms can be subtle or easily misunderstood, many people do not seek ...

Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial We propose that all patients ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...